Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1501-1510 of 9367

Page
per page
  1. ESI-09
    B4814 ESI-09
    Summary: EPAC inhibitor, specific
      ≥33.1 mg/mL
  2. LCZ696
    B4815 LCZ696
    Summary: A first in class ARNi (angiotensin receptor neprilysin inhibitor)
      ≥45.05 mg/mL
  3. WAY-262611
    B4818 WAY-262611
    Summary: β-Catenin agonist
      insoluble in EtOH; insoluble in H2O; ≥8.95 mg/mL
  4. Isavuconazole
    B4826 Isavuconazole
    Summary: triazole antifungal drug
      insoluble in H2O; ≥19.8 mg/mL
  5. JNJ-31020028
    B4827 JNJ-31020028
    Summary: selective brain penetrant antagonist of neuropeptide Y2 receptor
      Soluble in DMSO
  6. Efinaconazole
    B4834 Efinaconazole
    Summary: novel triazole antifungal drug
      insoluble in H2O; ≥13.95 mg/mL
  7. CPI-360
    B4836 CPI-360
    Summary: EZH2 inhibitor
      Soluble in DMSO
  8. BRD4770
    B4837 BRD4770
    Target: Histone Methyltransferase
    Summary: novel G9a(EHMT2) inhibitor
      insoluble in DMSO; insoluble in H2O; insoluble in EtOH
  9. ZLN024 hydrochloride
    B4840 ZLN024 hydrochloride
    Summary: novel AMPK allosteric activator
      ≥33.2 mg/mL
  10. LDN-214117
    B4842 LDN-214117
    Summary: potent and selective ALK2 inhibitor
      insoluble in H2O; ≥90 mg/mL

Items 1501-1510 of 9367

Page
per page